South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate.
Aspen said it had agreed to provide capacity required for the manufacture of J&J’s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility.
Aspen will perform formulation, filling and secondary packaging of the vaccine for supply to Johnson & Johnson, the company said.
Follow us on:
Anambra lacks formal crowd control law but is working on a regulatory framework, says state…
Retired Air Vice Marshal Akugbe Iyamu has called for urgent preparations for drought, heatwaves, and…
Romania's president Klaus Iohannis is expected to designate Prime Minister Marcel Ciolacu to form a…
Federal Government of Nigeria has declared public holidays to mark Christmas and New Year festivities…
IGP Egbetokun has ordered an investigation into Jimoh Abdulquadri’s death in police custody, promising justice…
Donald Trump has rejected suggestions that Elon Musk is the true influence behind the newly…